Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2017-09-21 to 2027-09-24
Current total value of award: $611318728
Description: NO COST MODIFICATION TO REVISE THE JOINT OVERSIGHT COMMITTEE MEMBERS AND EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0001 TO SEPT 25, 2027.